The CLTPM1L gene, also known as cisplatin resistance-related protein 9 (CRR9p), encodes a protein that is overexpressed in lung and pancreatic cancer, promotes growth and survival, and is required for KRAS driven lung cancer [31, 32]. Here, KRAS is linked to pancreatic neoplasm.